0001104659-16-107576.txt : 20160325
0001104659-16-107576.hdr.sgml : 20160325
20160325112153
ACCESSION NUMBER: 0001104659-16-107576
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160324
FILED AS OF DATE: 20160325
DATE AS OF CHANGE: 20160325
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc.
CENTRAL INDEX KEY: 0001626199
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208969493
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-945-7700
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Congleton Jon
CENTRAL INDEX KEY: 0001644975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37449
FILM NUMBER: 161529033
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
a4.xml
4
X0306
4
2016-03-24
0
0001626199
Nivalis Therapeutics, Inc.
NVLS
0001644975
Congleton Jon
C/O NIVALIS THERAPEUTICS, INC.
3122 STERLING CIRCLE, SUITE 200
BOULDER
CO
80301
1
1
0
0
President and CEO
Common Stock
2016-03-24
4
P
0
5000
4.2169
A
15000
D
The price recorded in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.25, inclusive. The reporting person undertakes to provide Nivalis Therapeutics, Inc., any security holder of Nivalis Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
/s/ R. Michael Carruthers, Attorney-in-Fact
2016-03-25